Covered recipient · General Payments record
MARITZA OROZCO-ROBLES
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$1,242.03
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $621.32 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $216.83 | 2 |
| ABBVIE INC. | $215.77 | 2 |
| Novo Nordisk AS | $104.77 | 1 |
| Acerta Pharma LLC | $47.79 | 3 |
| Lilly USA, LLC | $36.16 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $115.75 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107768248 | CMS |
| ABBVIE INC. | $100.02 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107768250 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.11 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105727923 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.77 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104674703 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.91 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105597989 | CMS |
| Daiichi Sankyo Inc. | $103.88 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089464920 | CMS |
| Daiichi Sankyo Inc. | $112.95 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089464918 | CMS |
| Lilly USA, LLC | $18.52 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135777034 | CMS |
| Lilly USA, LLC | $17.64 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135743624 | CMS |
| Novo Nordisk Inc | $104.77 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100633337 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.